Total Payments
$347.46
2022 Payments
$37.74
Companies
11
Transactions
22
Medicare Patients
570
Medicare Billing
$7,681
Payment Breakdown by Category
Food & Beverage$317.47 (91.4%)
Education$29.99 (8.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $317.47 | 21 | 91.4% |
| Education | $29.99 | 1 | 8.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $108.09 | 7 | $0 (2019) |
| Lilly USA, LLC | $42.09 | 3 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $37.74 | 2 | $0 (2022) |
| Allergan Inc. | $29.99 | 1 | $0 (2018) |
| Purdue Pharma L.P. | $28.05 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $27.23 | 2 | $0 (2019) |
| Mylan Specialty L.P. | $19.86 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $18.23 | 1 | $0 (2017) |
| PFIZER INC. | $13.94 | 1 | $0 (2019) |
| Amgen Inc. | $11.63 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $37.74 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($37.74) |
| 2021 | $13.21 | 1 | Lilly USA, LLC ($13.21) |
| 2020 | $17.67 | 1 | Lilly USA, LLC ($17.67) |
| 2019 | $75.70 | 5 | SANOFI-AVENTIS U.S. LLC ($27.23) |
| 2018 | $133.63 | 8 | Novo Nordisk Inc ($53.77) |
| 2017 | $69.51 | 5 | Novo Nordisk Inc ($39.65) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Cardio-renal | ||||||
| 07/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Cardio-renal | ||||||
| 04/21/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Diabetes | ||||||
| 11/12/2020 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Diabetes | ||||||
| 04/09/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: DIABETES | ||||||
| 03/11/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Diabetes | ||||||
| 02/13/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: DIABETES | ||||||
| 02/06/2019 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Respiratory and Allergy | ||||||
| 01/07/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 11/07/2018 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: Diabetes | ||||||
| 10/29/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Diabetes | ||||||
| 07/30/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Diabetes | ||||||
| 05/14/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2018 | Purdue Pharma L.P. | SYMPROIC (Drug) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: CONSTIPATION | ||||||
| 03/13/2018 | Purdue Pharma L.P. | SYMPROIC (Drug) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: CONSTIPATION | ||||||
| 03/12/2018 | Ironwood Pharmaceuticals, Inc | LINZESS (Drug), VIBERZI, DUZALLO | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: Gastroenterology | ||||||
| 01/23/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Diabetes | ||||||
| 10/24/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Diabetes | ||||||
| 07/24/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Diabetes | ||||||
| 07/17/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Respiratory | ||||||
| 03/13/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Diabetes | ||||||
| 02/22/2017 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 84 | 211 | $5,660 | $862.21 |
| 2022 | 5 | 145 | 232 | $5,587 | $838.59 |
| 2021 | 3 | 100 | 200 | $4,172 | $936.29 |
| 2020 | 4 | 241 | 602 | $16,264 | $5,044 |
Total Patients
570
Total Services
1,245
Medicare Billing
$7,681
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82947 | Blood glucose (sugar) level | Office | 2023 | 24 | 117 | $2,574 | $450.45 | 17.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 20 | 28 | $1,106 | $266.56 | 24.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 40 | 66 | $1,980 | $145.20 | 7.3% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 32 | 86 | $1,874 | $331.30 | 17.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 49 | 68 | $2,000 | $149.81 | 7.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 13 | 15 | $453.00 | $144.60 | 31.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 32 | 36 | $720.00 | $124.83 | 17.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 19 | 27 | $540.00 | $88.05 | 16.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 48 | 138 | $2,760 | $452.64 | 16.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 34 | 43 | $1,032 | $417.53 | 40.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 18 | 19 | $380.00 | $66.12 | 17.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 52 | $5,044 | $2,882 | 57.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 80 | 377 | $7,540 | $1,229 | 16.3% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 47 | 55 | $1,320 | $525.06 | 39.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 92 | 118 | $2,360 | $407.14 | 17.3% |
About Dr. Amrita Yearwood, MD
Dr. Amrita Yearwood, MD is a Internal Medicine healthcare provider based in Evergreen, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770559734.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amrita Yearwood, MD has received a total of $347.46 in payments from pharmaceutical and medical device companies, with $37.74 received in 2022. These payments were reported across 22 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($317.47).
As a Medicare-enrolled provider, Yearwood has provided services to 570 Medicare beneficiaries, totaling 1,245 services with total Medicare billing of $7,681. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Evergreen, AL
- Active Since 02/28/2006
- Last Updated 05/02/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770559734
Products in Payments
- Victoza (Drug) $57.71
- Tresiba (Drug) $50.38
- Kerendia (Drug) $37.74
- VRAYLAR (Drug) $29.99
- SYMPROIC (Drug) $28.05
- TOUJEO (Drug) $27.23
- Yupelri (Drug) $19.86
- SYMBICORT (Drug) $18.23
- BASAGLAR (Drug) $17.67
- LYRICA (Drug) $13.94
- TRULICITY (Drug) $13.21
- Repatha (Biological) $11.63
- JARDIANCE (Drug) $11.21
- LINZESS (Drug) $10.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Evergreen
Hector Salemi-Castro, M.d, M.D
Internal Medicine — Payments: $1,613
Internal Medicine $1,613
Martha Lynch-Biasi, Md, MD
Internal Medicine — Payments: $119.15
Internal Medicine $119.15
Patrice Thibodeau, M.d, M.D
Internal Medicine — Payments: $23.16
Internal Medicine $23.16
Dr. Marsha Manning, M.d, M.D
Internal Medicine
Internal Medicine
Dr. Anne Mclean, M.d, M.D
Internal Medicine
Internal Medicine
Dr. Theresa Donati, Md, MD
Internal Medicine
Internal Medicine